8.15am: AstraZeneca has raised fresh fears over its threadbare drug development pipeline, admitting that its heart drug AGI-1067 is a 'very high-risk project'. By Julia Kollewe.
The government's health advisers will tell people this week how companies must do more to get their staff on their feet in order to combat a nationwide epidemic of unfitness.
The architect of the government's decision to increase NHS spending by £40bn will today cause anxiety across Whitehall by launching an independent inquiry into how well the money was spent.